Self-testing involves using commercial kits or products to obtain diagnostic testing results without the direct oversight of a healthcare professional. Self-testing kits are available for conditions such as pregnancy, diabetes, lipids, fertility, and infections including HIV and STDs. The growing digitalization and smartphone revolution in healthcare has facilitated the adoption of self-testing products through online sales and mobile apps. Rapid self-testing kits provide results within minutes and help in the early detection of health conditions.
The global Self-Testing Market is estimated to be valued at Us$ 21867.72 Mn in 2023 and is expected to exhibit a CAGR Of 6.8% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The rising prevalence of chronic diseases such as diabetes, cardiac disorders, HIV/AIDS and STDs is driving the demand for self-testing products globally. As per the International Diabetes Federation, around 537 million adults were living with diabetes in 2021 worldwide, and the number is projected to rise to 783 million by 2045. Self-testing helps in the timely diagnosis and management of such chronic conditions. Furthermore, growing health awareness and convenience of self-testing is encouraging the adoption of these products. The Covid-19 pandemic further boosted the self-testing market as people preferred to self-monitor health parameters from the safety of their homes. However, reliability issues associated with self-testing may hamper the market growth.
SWOT Analysis
Strength: The self-testing market has seen growth due to the convenience it provides to users. It allows individuals to test for diseases from the comfort of their home without needing to visit laboratories or doctors. Self-testing kits are also affordable and provide quick results.
Weakness: Accuracy and reliability of results from self-testing kits have been a concern. User error during the testing process can lead to incorrect diagnosis. Self-testing also does not provide professional medical advice or confirmation of results.
Opportunity: Growing awareness about disease prevention and screening among consumers presents an opportunity. The covid-19 pandemic has further increased focus on self-monitoring of health. Demand is expected to rise for self-testing of chronic conditions like diabetes and cardiovascular diseases.
Threats: Stringent regulatory processes and safety standards for product approval pose a threat. Companies have to invest significantly in research and clinical validation before launching self-testing kits. The entry of local players offering low cost alternatives also increases competition.
Key Takeaways
The Global Self-Testing Market Demand is estimated to be valued at US$ 21867.72 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030.
North America currently dominates the market with the highest revenue share owing to rapid adoption of new diagnostic technologies. However, Asia Pacific region is anticipated to witness the highest growth in the self-testing market at a CAGR of over 8% during the forecast period. Factors such as growing geriatric population, increasing income levels, and government initiatives to spread awareness about diseases will drive market growth in Asia Pacific countries. China, India, and Japan account for the bulk of the region’s market share currently.
Key players :
Key players operating in the self-testing market are BNP Paribas, CVS Health, Aviva, Allianz, Humana, Cigna, Aetna, Wellcare Health Plans Inc., UnitedHealth Group Inc., and Nippon Life Insurance Company, among others. These companies offer a wide range of self-testing kits for conditions such as glucose, cholesterol, fertility, pregnancy, UTI, and HIV. They are focusing on product line expansions and partnerships with distributors to strengthen their presence across different regions.
Get more insights on this topic :
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian